BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37373025)

  • 1. Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells.
    Adinew GM; Messeha S; Taka E; Mochona B; Redda KK; Soliman KFA
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
    Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells.
    Messeha SS; Zarmouh NO; Antonie L; Soliman KFA
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
    Front Immunol; 2019; 10():757. PubMed ID: 31031757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells.
    Adinew G; Messeha SS; Badisa R; Taka E; Soliman KFA
    FASEB J; 2022 May; 36 Suppl 1():. PubMed ID: 35723877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
    Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effects of butein on cell proliferation and TNF-α-induced CCL2 release in racially different triple negative breast cancer cells.
    Mendonca P; Horton A; Bauer D; Messeha S; Soliman KFA
    PLoS One; 2019; 14(10):e0215269. PubMed ID: 31665136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
    Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages.
    Nordin FJ; Pearanpan L; Chan KM; Kumolosasi E; Yong YK; Shaari K; Rajab NF
    PLoS One; 2021; 16(8):e0256012. PubMed ID: 34379689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells.
    Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
    Front Immunol; 2019; 10():804. PubMed ID: 31105691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro.
    Khan MA; Zheng M; Fu J; Tania M; Li J; Fu J
    BMC Cancer; 2022 Jun; 22(1):707. PubMed ID: 35761256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
    Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
    Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentagalloyl glucose inhibits TNF-α-activated CXCL1/GRO-α expression and induces apoptosis-related genes in triple-negative breast cancer cells.
    Mendonca P; Alghamdi S; Messeha S; Soliman KFA
    Sci Rep; 2021 Mar; 11(1):5649. PubMed ID: 33707603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.
    Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, and Angiogenesis Inhibition in Triple-Negative Breast Cancer Cells.
    Ahmed SA; Mendonca P; Messeha SS; Soliman KFA
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
    Zheng M; Mei Z; Junaid M; Tania M; Fu J; Chen HC; Khan MA
    Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells.
    Adinew GM; Messeha SS; Taka E; Badisa RB; Soliman KFA
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.